Arizona Biotech News: Biotech News - inChord Communications Agencies and CEO to be Recognized at 17th Annual Med Ad N - BioTech News at Arizona Biotech

http://www.arizonabiotech.com/ http://groups.yahoo.com/group/biotech-news/ http://www.arizonaentrepreneurs.com/ http://www.azhttp.com/

	My Groups \| biotech-news Main Page

inChord Communications Agencies and CEO to be Recognized at 17th Annual Med Ad News Manny Awards

* Blane Walter, CEO of inChord, To Be Honored as Advertising Person of the
Year

* GSW Worldwide, The Navicor Group and Palio Communications Receive Award
Nominations

    COLUMBUS, Ohio, April 3 inChord Communications, now
inVentiv Communications, a division of inVentiv Health (Ventiv Health, Inc.,
Nasdaq: VTIV), and three of its advertising agencies will be honored by Med Ad
News on April 20 at the 17th annual Manny Awards, an awards program that
recognizes excellence among healthcare advertising agencies.
    R. Blane Walter, CEO of inChord Communications and president and CEO of
inVentiv Communications, will be honored as "Advertising Person of the Year."
The award is presented to a senior-level industry leader who, during the past
year, has made extraordinary professional achievements, elevated his or her
business to new heights, and advanced the industry through outstanding and
innovative actions. At age 35, Walter is the youngest person to ever receive
the award.
    In addition to recognizing Walter, Med Ad News has also nominated three
inChord agencies -- Palio Communications, The Navicor Group and GSW Worldwide
-- for 2006 Manny Awards. This year, the publication will present "Agency of
the Year" awards in three categories, based on revenue size. Palio
Communications is nominated for Agency of the Year in Category II ($10 - $50
million in revenue). The Navicor Group is nominated for Agency of the Year in
Category III ($2 to $10 million in revenue). Nominees for the Agency of the
Year Awards are judged on creative track record, management strength,
financial performance, strategic thinking, account wins and losses, and
ability to attract talent.
    GSW Worldwide is nominated for Most Creative Agency, an honor recognizing
the agency that has produced the most outstanding compilation of creative work
over the past year. In addition, GSW is nominated for Best Disease Awareness
Advertisement for an ad it created for TAP Pharmaceuticals in the
hyperuricemia category; and for Best Pro-Bono Advertisement for an ad it
created for Columbus Children's Hospital. All creative awards are determined
by votes from creative directors at the agencies polled by Med Ad News.
    "The Manny Awards are widely recognized to be one of the highest honors
within our industry," said Walter. "It is a tremendous distinction to be named
Advertising Person of the Year, but I'm even more proud of the nominations
that our agencies have received. They reinforce my conviction that we are
leading the industry with innovative thinking, strategic vision and creative
execution."
    Manny Award winners will be announced on April 20 at the awards ceremony,
to be held at the Sheraton New York Hotel and Towers in New York City.

inChord Communications is a global group of specialized communication
companies working together to provide customized marketing solutions to the
health and wellness industry, including many of the world's top pharmaceutical
and biotech companies. Based in Columbus, Ohio, inChord has more than 700
employees and offices in 11 major global markets. inChord is an inVentiv
Health company. For more information, please go to http://www.inchord.com.

About inVentiv Health
inVentiv Health (Ventiv Health, Inc., Nasdaq: VTIV) is the leading
provider of commercialization and complementary services to the global
pharmaceutical, life sciences and biotechnology industries. inVentiv delivers
its customized clinical, sales, marketing and communications solutions through
its three core business segments: inVentiv Clinical, inVentiv Communications,
and inVentiv Commercial. inVentiv Health works with over 150 pharmaceutical
and life sciences clients, including 18 of the top 20 global pharmaceutical
companies. For more information, visit http://www.inventivhealth.com.

This press release contains forward-looking statements within the meaning
of the Private Securities Litigation Reform Act of 1995. Such forward-looking
statements involve known and unknown risks that may cause Ventiv Health's
performance to differ materially. Such risks include, without limitation:
changes in trends in the pharmaceutical industry or in pharmaceutical
outsourcing; our ability to compete successfully with other services in the
market; our ability to maintain large client contracts or to enter into new
contracts; and, our ability to operate successfully in new lines of business.
Readers of this press release are referred to documents filed from time to
time by Ventiv Health, Inc. with the Securities and Exchange Commission for
further discussion of these and other factors.

YAHOO! GROUPS LINKS Visit your group "biotech-news" on the web. To unsubscribe from this group, send an email to: biotech-news-unsubscribe@yahoogroups.com Your use of Yahoo! Groups is subject to the Yahoo! Terms of Service.